Search Result "tolterodine"
The Design and Development of Fesoterodine as a Prodrug of 5- Hydroxymethyl Tolterodine (5-HMT), the Active Metabolite of Tolterodine
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2009 Page: 4481-4489
Author(s): B. Malhotra, K. Gandelman, R. Sachse, N. Wood, M. C. Michel
A Review on Analytical Method Development for the Estimation of a PotentMuscarinic Receptor Antagonist Tolterodine Tartrate
Journal: Current Pharmaceutical Analysis
Volume: 18 Issue: 6 Year: 2022 Page: 574-589
Author(s): Sasmita Kumari Acharjya,Sanat Kumar Dash
Determination of Tolterodine Via Ion Pair Complex Using Spectrophotometric Method in Pharmaceutical Formulation
Journal: Current Pharmaceutical Analysis
Volume: 14 Issue: 4 Year: 2018 Page: 367-372
Author(s): Munjed M. Ibrahim,Mohammed Alarjah
Design and Characterization of Sustained Release Mucoadhesive Microspheres of Tolterodine Tartrate
Journal: Current Drug Delivery
Volume: 10 Issue: 4 Year: 2013 Page: 413-426
Author(s): Suryakanta Swain, Dusmant Meher, Chinam Niranjan Patra, Jammula Sruti, Subas Chandra Dinda, Muddana Eswara Bhanoji Rao
Comparison of the Effect of Oral Sodium Bicarbonate and Tolterodine inWomen with Symptoms of Overactive Bladder with Acidic Urine- ASingle-Blind Randomized Clinical Trial
Journal: Current Women`s Health Reviews
Volume: 19 Issue: 4 Year: 2023 Page: 70-76
Author(s): Tayebeh Jahed Bozorgan
Overactive Bladder - Current Treatment Modalities
Journal: Current Women`s Health Reviews
Volume: 9 Issue: 2 Year: 2013 Page: 105-116
Author(s): Jayeeta Roy
New Pharmacologic Horizons in the Treatment of Benign Prostatic Hyperplasia
Journal: Current Drug Therapy
Volume: 5 Issue: 4 Year: 2010 Page: 262-270
Author(s): Yoshiyuki Kojima, Masa Hayase, Shoichi Sasaki, Yutaro Hayashi, Kenjiro Kohri
Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?
Journal: Current Drug Targets
Volume: 16 Issue: 11 Year: 2015 Page: 1187-1197
Author(s): Apostolos Apostolidis
Overactive Bladder (OAB) Management: An Overview and Scope of Nano Drug Carriers
Journal: Nanoscience & Nanotechnology-Asia
Volume: 11 Issue: 6 Year: 2021 Page: 4-12
Author(s): Vikash Kumar,Sandeep Rathor
The Current Indications and the Benefits of Combining a β3-Agonist with an Anticholinergic for the Treatment of OAB
Journal: Current Drug Targets
Volume: 16 Issue: 11 Year: 2015 Page: 1198-1206
Author(s): Cosimo De Nunzio,Fabrizio Presicce,Luisella Pirozzi,Pietro Castellan,Luigi Schips,Luca Cindolo,Riccardo Lombardo,Andrea Tubaro